These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 34048180)
1. Combination Therapy of TRAIL and Thymoquinone Induce Breast Cancer Cell Cytotoxicity-Mediated Apoptosis and Cell Cycle Arrest. Abdel Salam NM; Abd-Rabou AA; Sharada HM; El Samea GGA; Abdalla MS Asian Pac J Cancer Prev; 2021 May; 22(5):1513-1521. PubMed ID: 34048180 [TBL] [Abstract][Full Text] [Related]
2. Thymoquinone Crosstalks with DR5 to Sensitize TRAIL Resistance and Stimulate ROS-Mediated Cancer Apoptosis. Abd-Rabou AA; Abd El-Salam NM; Sharada HMI; Abd El Samea GG; Abdalla MS Asian Pac J Cancer Prev; 2021 Sep; 22(9):2855-2865. PubMed ID: 34582654 [TBL] [Abstract][Full Text] [Related]
3. Thymoquinone Augments Cyclophosphamide-Mediated Inhibition of Cell Proliferation in Breast Cancer Cells. Khan A; Aldebasi YH; Alsuhaibani SA; Khan MA Asian Pac J Cancer Prev; 2019 Apr; 20(4):1153-1160. PubMed ID: 31030489 [TBL] [Abstract][Full Text] [Related]
4. Thymoquinone Alterations of the Apoptotic Gene Expressions and Cell Cycle Arrest in Genetically Distinct Triple-Negative Breast Cancer Cells. Adinew GM; Messeha SS; Taka E; Badisa RB; Antonie LM; Soliman KFA Nutrients; 2022 May; 14(10):. PubMed ID: 35631261 [TBL] [Abstract][Full Text] [Related]
5. Thymoquinone upregulates TRAIL/TRAILR2 expression and attenuates hepatocellular carcinoma in vivo model. Helmy SA; El-Mesery M; El-Karef A; Eissa LA; El Gayar AM Life Sci; 2019 Sep; 233():116673. PubMed ID: 31336121 [TBL] [Abstract][Full Text] [Related]
6. Anti-tumor Effects of IL-1β Induced TRAIL-Expressing hUCMSCs on Embelin Treated Breast Cancer Cell Lines. Teng JW; Hung E; Wu JM; Liang YH; Chiu YH; Tyan YS; Wang HS Asian Pac J Cancer Prev; 2023 Apr; 24(4):1297-1305. PubMed ID: 37116152 [TBL] [Abstract][Full Text] [Related]
7. Concurrent Reactive Oxygen Species Generation and Aneuploidy Induction Contribute to Thymoquinone Anticancer Activity. Al-Hayali M; Garces A; Stocks M; Collins H; Bradshaw TD Molecules; 2021 Aug; 26(17):. PubMed ID: 34500570 [TBL] [Abstract][Full Text] [Related]
8. Combinatorial therapy of Thymoquinone and Emodin synergistically enhances apoptosis, attenuates cell migration and reduces stemness efficiently in breast cancer. Bhattacharjee M; Upadhyay P; Sarker S; Basu A; Das S; Ghosh A; Ghosh S; Adhikary A Biochim Biophys Acta Gen Subj; 2020 Nov; 1864(11):129695. PubMed ID: 32735937 [TBL] [Abstract][Full Text] [Related]
9. Thymoquinone sensitizes human hepatocarcinoma cells to TRAIL-induced apoptosis via oxidative DNA damage. Zhang R; Wu T; Zheng P; Liu M; Xu G; Xi M; Yu J DNA Repair (Amst); 2021 Jul; 103():103117. PubMed ID: 33990030 [TBL] [Abstract][Full Text] [Related]
10. Molecular targeting of Akt by thymoquinone promotes G(1) arrest through translation inhibition of cyclin D1 and induces apoptosis in breast cancer cells. Rajput S; Kumar BN; Dey KK; Pal I; Parekh A; Mandal M Life Sci; 2013 Nov; 93(21):783-90. PubMed ID: 24044882 [TBL] [Abstract][Full Text] [Related]
11. Curcumin and Thymoquinone Combination Attenuates Breast Cancer Cell Lines' Progression. El-Far AH; Saddiq AA; Mohamed SA; Almaghrabi OA; Mousa SA Integr Cancer Ther; 2022; 21():15347354221099537. PubMed ID: 35583244 [TBL] [Abstract][Full Text] [Related]
12. Enhanced expression of death receptor 5 is responsible for increased cytotoxicity of theophylline in combination with recombinant human TRAIL in MDA-MB-231 breast cancer cells. Tapadar P; Pal A; Dutta S; Pal R J Cancer Res Ther; 2022; 18(3):754-759. PubMed ID: 35900550 [TBL] [Abstract][Full Text] [Related]
13. Thymoquinone up-regulates PTEN expression and induces apoptosis in doxorubicin-resistant human breast cancer cells. Arafa el-SA; Zhu Q; Shah ZI; Wani G; Barakat BM; Racoma I; El-Mahdy MA; Wani AA Mutat Res; 2011 Jan; 706(1-2):28-35. PubMed ID: 21040738 [TBL] [Abstract][Full Text] [Related]
14. Trailing TRAIL Resistance in Human Breast Adenocarcinoma Cells with Trichostatin A and Zebularine. Wong SHM; Fang CM; Loh HS; Ngai SC Anticancer Agents Med Chem; 2023; 23(7):817-831. PubMed ID: 36380402 [TBL] [Abstract][Full Text] [Related]
15. Tumor Cell-selective Synergism of TRAIL- and ATRA-induced Cytotoxicity in Breast Cancer Cells. Reinhardt A; Liu H; Ma Y; Zhou Y; Zang C; Habbel JP; Possinger K; Eucker J Anticancer Res; 2018 May; 38(5):2669-2682. PubMed ID: 29715087 [TBL] [Abstract][Full Text] [Related]
16. Synergistic Role of Thymoquinone on Anticancer Activity of 5-Fluorouracil in Triple Negative Breast Cancer Cells. Zheng M; Mei Z; Junaid M; Tania M; Fu J; Chen HC; Khan MA Anticancer Agents Med Chem; 2022; 22(6):1111-1118. PubMed ID: 34170813 [TBL] [Abstract][Full Text] [Related]
17. Pretreatment with AT-101 enhances tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis of breast cancer cells by inducing death receptors 4 and 5 protein levels. Kisim A; Atmaca H; Cakar B; Karabulut B; Sezgin C; Uzunoglu S; Uslu R; Karaca B J Cancer Res Clin Oncol; 2012 Jul; 138(7):1155-63. PubMed ID: 22411600 [TBL] [Abstract][Full Text] [Related]
18. Evaluation of Enhanced Cytotoxicity Effect of Repurposed Drug Simvastatin/Thymoquinone Combination against Breast Cancer Cell Line. Kumari P; Dang S Cardiovasc Hematol Agents Med Chem; 2024; 22(3):348-366. PubMed ID: 37907488 [TBL] [Abstract][Full Text] [Related]
19. Low Doses of Thymoquinone and Ferulic Acid in Combination Effectively Inhibit Proliferation of Cultured MDA-MB 231 Breast Adenocarcinoma Cells. Al-Mutairi A; Rahman A; Rao MS Nutr Cancer; 2021; 73(2):282-289. PubMed ID: 32223348 [TBL] [Abstract][Full Text] [Related]
20. Anticancer Activity of Thymoquinone Cubic Phase Nanoparticles Against Human Breast Cancer: Formulation, Cytotoxicity and Subcellular Localization. Mehanna MM; Sarieddine R; Alwattar JK; Chouaib R; Gali-Muhtasib H Int J Nanomedicine; 2020; 15():9557-9570. PubMed ID: 33293807 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]